Generic Competition Studied to Determine Effects on Brand Drug
| Industry | Pharmaceutical Manufacturer |
| Problem | The client developed an injectable brand product and partnered with a leading manufacturer for marketing. Although they have several other products in their pipeline, this drug represented a substantial portion of corporate revenues and the manufacturer was concerned about the potential for generic competition. |
| PHSI Solution | PHSI researched the generic approval process, generic erosion of comparable brand markets, barriers to generic competition, and strategies to mitigate generic competition. Research was developed from a variety of sources including national sales data. |
| Results | The research presented strategies that a generic competitor might use to gain approval and enter the market. The information was used to direct the company’s future product development, budgeting, and revenues projections. |
Poll Results
August 2023 Question of the Month
What steps do you take when learning about an electronic prescribing challenge?
Root cause analysis: 0%
Compendia review: 0%
Engage a partner: 0%
All of the above: 50%
None of the above: 50%
July 2023 Question of the Month
Does your organization have a strategy for Humira biosimilar launches?
Yes, well defined: 0%
We have a framework: 50%
Waiting for clarity: 0%
No: 0%
Unaware of need: 50%
June 2023 Question of the Month
How far in advance of NDA/BLA expected approval do (or should) manufacturers begin planning their compendia submission strategy?
During Phase II Trials: 0%
Initiation of Phase III Trials: 66%
6 months prior to approval: 33%
3 months prior to approval: 0%
At time of approval: 0%
After approval: 0%
No strategy: 0%
Contact
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe:
